1H NMR-Based Metabolomics Coupled With Molecular Docking Reveal the Anti-Diabetic Effects and Potential Active Components of Berberis vernae on Type 2 Diabetic Rats

Qi Li, Chengcheng Zhao, Yunsen Zhang, Huan Du, Tong Xu, Xinmei Xu, Jing Zhang, Tingting Kuang, Xianrong Lai, Gang Fan, Yi ZhangFrontiers in Pharmacology 2020 · DOI

Abstract

The dried stem bark of Berberis vernae C.K.Schneid., known as "Xiao-bo-pi" in traditional Tibetan medicine, is a recognized anti-diabetic herb. This study integrates $^1$H NMR-based metabolomics, biochemical assays, molecular docking, and network analysis to evaluate its efficacy in type 2 diabetic (T2DM) rats. Results indicate that B. vernae extract significantly improves glycemic control, insulin sensitivity, and inflammatory markers. Metabolomic analysis identified 28 endogenous metabolites, 9 of which were significantly reversed by the treatment. Molecular docking highlighted ferulic acid 4-O-β-D-glucopyranoside, bufotenidine, jatrorrhizine, and berberine as key active components.

Introduction

Type 2 Diabetes Mellitus (T2DM) is a global health crisis characterized by insulin resistance and chronic systemic inflammation. Traditional Tibetan medicine has long utilized Berberis vernae for treating "wasting-thirst" diseases, yet the specific molecular mechanisms and active constituents have remained largely uncharacterized. This research aims to bridge the gap between traditional knowledge and modern pharmacology using a systems biology approach, identifying how this herb modulates complex metabolic and signaling networks.

Methodology

The study employed a multi-disciplinary workflow to decode the herb's effects:

  1. Animal Model Induction: Sprague-Dawley rats were fed a high-fat diet and administered Streptozotocin (STZ) to induce T2DM.
  2. Metabolomic Profiling: Proton Nuclear Magnetic Resonance ($^1$H NMR) was used to capture a holistic snapshot of serum metabolites. This non-targeted approach allows for the observation of systemic metabolic shifts.
  3. Chemical Characterization: High-Performance Liquid Chromatography (HPLC) quantified the primary constituents of the B. vernae extract, including magnoflorine and bufotenidine.
  4. Network Pharmacology: Researchers utilized molecular docking (Maestro) and network analysis (Cytoscape) to simulate interactions between the herb's compounds and 44 disease-related proteins, constructing a Compound-Protein-Metabolite-Disease (CPMD) network.
1H NMR spectra of serum from normal (A), model (B), and B. vernae-treated (C) rats, highlighting the identified endogenous metabolites.

Results and Discussion

Metabolic Reversal and Systemic Impact

The $^1$H NMR analysis identified 28 endogenous metabolites. Multivariate statistical analysis, including PCA and OPLS-DA, demonstrated a clear separation between the normal, diabetic model, and treated groups, indicating a significant shift in the metabolic profile following disease induction and subsequent herbal treatment.

Multivariate statistical analysis (PCA and OPLS-DA) demonstrating the metabolic trajectory and separation between control (N), diabetic model (M), and B. vernae-treated (SY) groups.

Treatment with B. vernae significantly reversed the levels of 9 key metabolites, including glucose, betaine, and various lipids. Biochemically, the extract reduced fasting blood glucose (FBG) from ~21.70 mmol/L to ~17.91 mmol/L and significantly lowered pro-inflammatory cytokines such as TNF-α (from ~299 pg/mL to ~189 pg/mL), IL-1β, and IL-6.

Identification of Active Components

Molecular docking revealed that four compounds—ferulic acid 4-O-β-D-glucopyranoside, bufotenidine, jatrorrhizine, and berberine—exhibited high affinity for T2DM-related protein targets. Notably, ferulic acid 4-O-β-D-glucopyranoside showed a 100% hit rate across all 44 target proteins, suggesting it is a primary driver of the herb's therapeutic efficacy.

Pathway Analysis

The anti-diabetic mechanisms appear linked to the regulation of the adipocytokine signaling pathway and butanoate metabolism. These findings suggest that B. vernae works by improving lipid signaling and energy homeostasis while simultaneously dampening the systemic inflammation that drives insulin resistance.

Conclusion

This study provides a comprehensive scientific basis for the traditional use of Berberis vernae in treating T2DM. By integrating metabolomics with computational docking, the researchers identified specific active compounds and metabolic pathways targeted by the herb. While these results are promising, further in vitro and clinical studies are necessary to validate the activity of individual compounds and ensure safety and efficacy in human populations.

Summary updated

Abstract

The dried stem bark of <i>Berberis vernae</i> C.K.Schneid., known as "Xiao-bo-pi" in Chinese, is a representative anti-diabetic herb in traditional Tibetan medical system. However, its anti-diabetic mechanisms and active components remain unclear. In this study, <sup>1</sup>H NMR-based metabolomics, biochemistry assay, molecular docking, and network analysis were integrated to evaluate the anti-diabetic effects of <i>B. vernae</i> extract on type 2 diabetic rats, and to explore its active components and underlying mechanisms. Diabetes was induced by high-fat diet and streptozotocin. After 30 days of treatment, <i>B. vernae</i> extract significantly decreased the serum levels of fasting blood glucose, insulin, insulin resistance index, glycated serum protein, TNF-α, IL-1β, and IL-6, whereas significantly increased the serum levels of insulin sensitivity index in type 2 diabetic rats. A total of 28 endogenous metabolites were identified by <sup>1</sup>H NMR-based metabolomics, of which 9 metabolites that were changed by diabetes were significantly reversed by <i>B. vernae</i> extract. The constructed compound-protein-metabolite-disease (CPMD) interaction network revealed the correlation between chemical constituents, target proteins, differential metabolites, and type 2 diabetes. Ferulic acid 4-<i>O</i>-<i>β</i>-D-glucopyranoside, bufotenidine, jatrorrhizine, and berberine showed good hit rates for both the 30 disease-related proteins and 14 differential metabolites-related proteins, indicating that these four compounds might be the active ingredients of <i>B. vernae</i> against type 2 diabetes. Moreover, pathway analysis revealed that the anti-diabetic mechanisms of <i>B. vernae</i> might be related to its regulation of several metabolic pathways (e.g., butanoate metabolism) and disease-related signal pathways (e.g., adipocytokine signaling pathway). In summary, <i>B. vernae</i> exerts a significant anti-diabetic effect and has potential as a drug candidate for the treatment of type 2 diabetes.
BibTeX
@inproceedings{li2020h,
  author = {Qi Li and Chengcheng Zhao and Yunsen Zhang and Huan Du and Tong Xu and Xinmei Xu and Jing Zhang and Tingting Kuang and Xianrong Lai and Gang Fan and Yi Zhang},
  title = {{1H NMR-Based Metabolomics Coupled With Molecular Docking Reveal the Anti-Diabetic Effects and Potential Active Components of Berberis vernae on Type 2 Diabetic Rats}},
  booktitle = {Frontiers in Pharmacology},
  year = {2020},
  doi = {10.3389/fphar.2020.00932},
}
Figure